Aradigm Corporation Employee Directory

Biotechnology ResearchUnited States51-200 Employees

Aradigm Corporation is a United States–based biotechnology company focused on inhaled therapies for severe respiratory diseases. It develops and commercializes a portfolio of drugs delivered by inhalation, leveraging its pulmonary drug-delivery expertise and a broad intellectual property portfolio. The company’s strategic approach includes advancing proprietary respiratory therapies and pursuing regulatory paths intended to streamline product development. Additionally, it outsources late-stage manufacturing to conserve capital and uses a specialized sales force to serve pulmonologists in the United States while licensing out technology and IP beyond its core interests.

The company serves pulmonologists and patients in the United States, operating as a mid-sized organization within the biotechnology research sector. In 2020, Aradigm completed the sale of assets and intellectual property to Grifols Canada Therapeutics Inc, including three ciprofloxacin formulations.

Sign up for free to view info

Company overview Email format